Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 2010

View Archived Issues

HemaQuest begins phase II HQK-1004 trial in EBV-related malignancies

Domain Therapeutics claims new adenosine A2A receptor antagonists

Avalon Pharma discloses new modulators of gene expression

Bristol-Myers Squibb describes new inhibitors of beta-amyloid production

Abbott claims new PARP-1 inhibitors

Rigel Pharmaceuticals discovers new PKC inhibitors

Starpharma begins phase II trial of VivaGel in bacterial vaginosis

Serum PICP level may predict profibrotic state and risk of hypertrophic cardiomyopathy

Beta-amyloid(1-42)/P-tau181P biomarker mixture model detects Alzheimer's disease pathology

Probenecid and cilastatin reduce cardiac fibrosis and myocyte hypertrophy ex vivo

Zoniporide exhibits cardioprotective effect in preclinical study

In vitro repopulation of lung matrix yields bioartificial lungs suitable for in vivo implantation

European Commission grants orphan designation to Vertex's cystic fibrosis candidate

Lilly reports key events of past quarter

BiondVax obtains approval for phase II trial of universal influenza vaccine

Cryo-Cell and Monash University enter into autoimmune disease collaboration

Mesoblast provides update on phase III bone marrow transplant program

Palatin Technologies reports phase I safety data on bremelanotide in ED

Medtronic complements bone healing portfolio with Osteotech acquisition

European Commission grants midostaurin orphan drug status in mastocytosis

Lilly decides to halt development of semagacestat for AD

BioMarin to evaluate neuropsychiatric effects of Kuvan in phase IIIb trial in PKU

Depomed to begin phase III trial of Serada for menopausal hot flashes

Oxford BioMedica and Emergent announce licensing agreement

Phylogica and MedImmune join to identify antimicrobial peptides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...